Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.

Source:http://linkedlifedata.com/resource/pubmed/id/18815361

Proc. Natl. Acad. Sci. U.S.A. 2008 Sep 30 105 39 14981-6

Download in:

View as

Triples

General Info

PMID
18815361